Fig. 6From: System analysis based on the pyroptosis-related genes identifes GSDMD as a novel therapy target for skin cutaneous melanomaThe screened drugs for SKCM treatment. IC50 value of SB525334 (A), SR8278 (B), Gemcitabine (C), AT13387 (D) in high- and low-risk patients with SKCM. The corresponding 3D structures are shown in E, F, G and H, respectivelyBack to article page